✅ New API: 6000+ US Stock Options End-of-Day Data with 40+ fields. Learn more

Centessa Pharmaceuticals PLC ADR (CNTA NASDAQ) stock market data APIs

$22.0258 0.33(1.5%)
as of September 12, 2025
Try our APIs with free plan!

Centessa Pharmaceuticals PLC ADR Financial Data Overview

Price chart is built with Anychart
OpenFigi: BBG01081**** The data is available with plans that include the Fundamentals API. Check our pricing page for details. CIK: 000184**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Prev. Close 22.0258
Open 22.3575
High 22.612
Low 21.6093
52 wk Range 9.6-23.24
Market Cap 2 924 M
Shares Outstanding 134 M
Revenue 15 000 K
EPS -0.38
Beta 1.481

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


ETFs with Centessa Pharmaceuticals PLC ADR (top by weight)

Ticker
100-day Price Change
Weight
BBC.US Virtus LifeSci Biotech Clinical Trials ETF
3.59 (17.46%)
1.33
2B70.XETRA iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
0.55 (10.08%)
0.21
2B70.F iShares NASDAQ US Biotechnology UCITS ETF
0.5 (9.15%)
0.21
GWX.US SPDR® S&P International Small Cap ETF
4.54 (12.71%)
0.14

* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Centessa Pharmaceuticals PLC ADR data using free add-ons & libraries


Get Centessa Pharmaceuticals PLC ADR Fundamental Data

Centessa Pharmaceuticals PLC ADR Fundamental data includes:

  • Net Revenue: 15 000 K
  • EBITDA: -206 106 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Centessa Pharmaceuticals PLC ADR Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-08-12
  • EPS/Forecast: -0.3297
GET THE PACKAGE

Get Centessa Pharmaceuticals PLC ADR End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Centessa Pharmaceuticals PLC ADR News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat